Skadden advised Goldman Sachs (Asia) L.L.C., China International Capital Corporation Hong Kong Securities Limited and Credit Suisse (Hong Kong) Limited as lead underwriters on the IPO....
Clover Biopharmaceuticals’ US$257.8 Million Hong Kong Initial Public Offering
Kanzhun Limited’s US$912 Million Initial Public Offering
Skadden, Arps, Slate, Meagher & Flom LLP, Latham & Watkins and Harneys advised Kanzhun Limited in the transaction. Kanzhun Limited, the largest online recruitment platform in...